Revelation’s net income for the three months ended March 31, 2023 was $6.2 million, or $2.79 basic earnings per share and $1.96 diluted earnings per share, compared to a net loss of $6.6 million, or ...
SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback